The live launch event will include a panel discussion between Paul Kippax and Deborah Huck-Jones, both of Malvern Panalytical, together with Caroline German, Technical Director, and Gregg Imrie, Computer Systems Validation Expert, both of Concept Life Sciences.
October 07 2020
MALVERN, UK: Malvern Panalytical will unveil OmniTrust, a new suite of data integrity solutions, at a live online event on 13 October. OmniTrust delivers integrated access, audit, and system validation services across a range of Malvern Panalytical instruments. This provides a common approach for compliance with regulatory requirements for data lifecycle management and protects the integrity of analytical workflows, giving customers confidence in their critical development and manufacturing decisions.
Product Group Manager Deborah Huck-Jones said, “In developing OmniTrust, we’ve really studied our customers’ workflows to understand their challenges and identify the bottlenecks in their control and review processes. Decisions that affect data integrity begin before a measurement has even been made, so we started at the point when a customer is looking to purchase an instrument and worked through how they then use and validate their system. The result is a combination of services and software that gives them greater transparency in their records and absolute confidence in the integrity of their data.”
OmniTrust is underpinned by Amplify Analytics, which delivers a range of flexible services to accelerate and de-risk drug development. This powerful combination provides the analytics know-how, instrumentation and validation support that enables customers to speed successful development whilst easing the regulatory burden associated with data integrity and compliance.
“In today’s fast-paced pharmaceutical development environment, our customers are balancing the race to drive innovation and improve productivity with the requirement to ensure compliance within complex regulatory frameworks,” said Paul Kippax, Sector Director. “At Malvern Panalytical, we understand that accessing our cutting-edge analytical techniques can help speed lifesaving pharmaceutical products to market. Amplify Analytics, supported by OmniTrust solutions, ensures you apply the right methods, delivering the right data at the right time to inform critical development and manufacturing decisions.”
The live launch event will include a panel discussion between Paul Kippax and Deborah Huck-Jones, both of Malvern Panalytical, together with Caroline German, Technical Director, and Gregg Imrie, Computer Systems Validation Expert, both of Concept Life Sciences. The panel discussion, streamed live from Malvern Panalytical’s UK headquarters, will be immediately followed by a dedicated Q&A session.
For more information about OmniTrust, Amplify Analytics, and Malvern Panalytical’s full suite of data integrity solutions, please join us on October 13th for the live launch event.
Malvern Panalytical technologies are used by scientists and engineers in a wide range of industries and organizations to solve the challenges associated with maximizing productivity, developing better quality products and getting them to market faster. Our focus is on creating innovative, customer-focused solutions and services to enhance efficiency and deliver tangible economic impact through chemical, physical and structural analysis of materials, making lives better across the world.
Concept Life Sciences is a contract research organization working to solve complex human health challenges in the pharmaceutical, biotechnology, agrochemical, chemical and food industry. We address these through continuous innovation, exceptional science and the highest customer service. We accelerate our customer’s discovery and development workflows and ensure product support through the application of our expertise to their challenges. We supply a wide range of services, from initial discovery through to development and API manufacture for clinical trials.